Suppr超能文献

奥地利蒂罗尔地区实行十五年机会性乳腺 X 光筛查后的乳腺癌发病率和死亡率。

Breast cancer incidence and mortality in Tyrol/Austria after fifteen years of opportunistic mammography screening.

机构信息

Department of Clinical Epidemiology of the Tyrolean State Hospitals Ltd, Cancer Registry of Tyrol, Innsbruck, Austria.

出版信息

BMC Public Health. 2010 Feb 20;10:86. doi: 10.1186/1471-2458-10-86.

Abstract

BACKGROUND

The aim of this study was to analyse breast cancer incidence and mortality in Tyrol from 1970 to 2006, namely after performing more than a decade of opportunistic mammography screening and just before piloting an organised screening programme. Our investigation was conducted on a population level.

METHODS

To study time trends in breast cancer incidence and mortality, we applied the age-period-cohort model by Poisson regression to the official mortality data covering more than three decades from 1970 to 2006 and to the incidence data ranging from 1988 to 2006. In addition, for incidence data we analysed data on breast cancer staging and compared these with EU guidelines.

RESULTS

For the analysis of time trend in breast cancer mortality in age groups 40-79, an age-period-cohort model fits well and shows for years 2002-2006 a statistically significant reduction of 26% (95% CI 13%-36%) in breast cancer mortality as compared to 1992-1996. We see only slight non-significant increases in breast cancer incidence. For the past five years, incidence data show a 10% proportion of in situ cases, and of 50% for cases in stages II+.

CONCLUSIONS

The opportunistic breast cancer screening programme in Tyrol has only in part exploited the mortality reduction known for organised screening programmes. There seems to be potential for further improvement, and we recommend that an organised screening programme and a detailed screening database be introduced to collect all information needed to analyse the quality indicators suggested by the EU guidelines.

摘要

背景

本研究旨在分析 1970 年至 2006 年蒂罗尔地区的乳腺癌发病率和死亡率,这段时期经历了十多年的机会性乳房 X 线筛查,并且在试行有组织的筛查计划之前。我们的研究是在人群水平上进行的。

方法

为了研究乳腺癌发病率和死亡率的时间趋势,我们应用泊松回归的年龄-时期-队列模型,对官方死亡率数据进行了分析,这些数据涵盖了 1970 年至 2006 年的三十多年,以及 1988 年至 2006 年的发病率数据。此外,我们还对乳腺癌分期的发病率数据进行了分析,并将其与欧盟指南进行了比较。

结果

在 40-79 岁年龄组中,对乳腺癌死亡率的时间趋势进行分析,年龄-时期-队列模型拟合良好,显示 2002-2006 年与 1992-1996 年相比,乳腺癌死亡率统计学上显著降低了 26%(95%CI 13%-36%)。我们只观察到乳腺癌发病率略有、无统计学意义的增加。过去五年,发病率数据显示原位病例的比例为 10%,II+期病例的比例为 50%。

结论

蒂罗尔的机会性乳腺癌筛查计划只在一定程度上利用了有组织的筛查计划所带来的死亡率降低。似乎还有进一步改善的空间,我们建议引入有组织的筛查计划和详细的筛查数据库,收集所有必要的信息,以分析欧盟指南建议的质量指标。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0620/2843664/ac076cb63d02/1471-2458-10-86-1.jpg

相似文献

2
Introduction of organised mammography screening in Tyrol: results of a one-year pilot phase.
BMC Public Health. 2011 Feb 9;11:91. doi: 10.1186/1471-2458-11-91.
5
Reduction in advanced breast cancer after introduction of a mammography screening program in Tyrol/Austria.
Breast. 2017 Jun;33:178-182. doi: 10.1016/j.breast.2017.04.002. Epub 2017 Apr 15.
6
Mammography service screening and breast cancer mortality in New Zealand: a National Cohort Study 1999-2011.
Br J Cancer. 2017 Mar 14;116(6):828-839. doi: 10.1038/bjc.2017.6. Epub 2017 Feb 9.
7
Trends in breast cancer by race and ethnicity: update 2006.
CA Cancer J Clin. 2006 May-Jun;56(3):168-83. doi: 10.3322/canjclin.56.3.168.
8
Breast cancer incidence and mortality before and after implementation of the German mammography screening program.
Int J Cancer. 2020 Aug 1;147(3):709-718. doi: 10.1002/ijc.32767. Epub 2019 Dec 4.

引用本文的文献

1
Breast cancer patterns by age groups in Brazil: insights from population-based registries data.
BMC Cancer. 2025 Jan 6;25(1):18. doi: 10.1186/s12885-024-13381-5.
2
Age differences in mammography screening reconsidered: life course trajectories in 13 European countries.
Eur J Public Health. 2015 Apr;25(2):314-20. doi: 10.1093/eurpub/cku077. Epub 2014 Jul 4.
4
Introduction of organised mammography screening in Tyrol: results of a one-year pilot phase.
BMC Public Health. 2011 Feb 9;11:91. doi: 10.1186/1471-2458-11-91.

本文引用的文献

1
Effects of mammography screening under different screening schedules: model estimates of potential benefits and harms.
Ann Intern Med. 2009 Nov 17;151(10):738-47. doi: 10.7326/0003-4819-151-10-200911170-00010.
2
Screening for breast cancer: U.S. Preventive Services Task Force recommendation statement.
Ann Intern Med. 2009 Nov 17;151(10):716-26, W-236. doi: 10.7326/0003-4819-151-10-200911170-00008.
4
Are survival rates for Tyrol published in the Eurocare studies biased?
Acta Oncol. 2009;48(7):984-91. doi: 10.1080/02841860903188635.
5
Bias associated with self-report of prior screening mammography.
Cancer Epidemiol Biomarkers Prev. 2009 Jun;18(6):1699-705. doi: 10.1158/1055-9965.EPI-09-0020.
6
European guidelines for quality assurance in breast cancer screening and diagnosis. Fourth edition--summary document.
Ann Oncol. 2008 Apr;19(4):614-22. doi: 10.1093/annonc/mdm481. Epub 2007 Nov 17.
7
The decrease in breast-cancer incidence in 2003 in the United States.
N Engl J Med. 2007 Apr 19;356(16):1670-4. doi: 10.1056/NEJMsr070105.
8
Screening for breast cancer with mammography.
Cochrane Database Syst Rev. 2006 Oct 18(4):CD001877. doi: 10.1002/14651858.CD001877.pub2.
9
Breast cancer trends: opportunistic screening in Austria versus controlled screening in Finland and Sweden.
Eur J Cancer Prev. 2006 Aug;15(4):343-6. doi: 10.1097/00008469-200608000-00007.
10
Reduction in breast cancer mortality from organized service screening with mammography: 1. Further confirmation with extended data.
Cancer Epidemiol Biomarkers Prev. 2006 Jan;15(1):45-51. doi: 10.1158/1055-9965.EPI-05-0349.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验